SureTrader
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

My point is that since About July of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
flipper44 Member Profile
Member Level 
Followed By 73
Posts 10,917
Boards Moderated 0
Alias Born 11/14/13
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 1/10/2018 2:02:52 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 1/9/2018 4:31:55 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/9/2018 12:25:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/5/2018 5:13:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/4/2018 4:29:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/21/2017 8:02:14 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/7/2017 4:33:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/5/2017 5:25:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/21/2017 6:05:58 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/20/2017 5:33:26 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 11/14/2017 5:20:39 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/24/2017 3:19:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2017 5:28:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2017 5:11:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2017 4:18:34 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/22/2017 8:58:57 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/11/2017 2:46:27 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/11/2017 2:41:35 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/21/2017 4:40:00 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/15/2017 4:12:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/8/2017 5:28:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 5:24:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/7/2017 5:19:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 1:14:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/26/2017 3:21:58 PM
flipper44 Member Level  Friday, 01/12/18 03:44:05 PM
Re: SheemaGato post# 153161
Post # of 153514 
My point is that since About July of 2015 I've been watching Cognate hiring. Installation of clean rooms for Cognate and advent at same time by same manufacturer. I've watched NWBO add language to their last 10q that they are currently working on expanding for DCVax-l production in UK and Europe in addition to currently negotiating said contracts. I am following NICE and paying attention to how that timing indicates possibility of earlier approval back home in the U.S. I'm watching the fact that the public should be receiving a DCVax-l publication any day. I'm watching guidances that may help DCVax-l early AA if they were successful.

Sure, Cognate might be expanding for somebody else, but I'd lean toward their primary expansion being for DCVax-l.


Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist